Alanagreh L, Alzoughool F, Atoum M. The human coronavirus disease COVID-19: its origin, characteristics, and insights into potential drugs and its mechanisms. Pathogens. 2020;9:331.
Article
CAS
Google Scholar
Amoutzias GD, Nikolaidis M, Tryfonopoulou E, Chlichlia K, Markoulatos P, Oliver SG. The remarkable evolutionary plasticity of Coronaviruses by Mutation and recombination: insights for the COVID-19 pandemic and the future evolutionary paths of SARS-CoV-2. Viruses. 2022;14:78.
Article
CAS
Google Scholar
Bao Y, Sun Y, Meng S, Shi J, Lu L. 2019-nCoV epidemic: address mental health care to empower society. Lancet. 2020;395:e37-8.
Article
CAS
Google Scholar
Dumonteil E, Herrera C. Polymorphism and selection pressure of SARS-CoV-2 vaccine and diagnostic antigens: implications for immune evasion and serologic diagnostic performance. Pathogens. 2020;9:584.
Article
CAS
Google Scholar
Golawski M, Lewandowski P, Jablonska I, Delijewski M. The reassessed potential of SARS-CoV-2 attenuation for COVID-19 Vaccine Development-A systematic review. Viruses. 2022;14:991.
Article
CAS
Google Scholar
Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi RS, Marrama D, de Silva AM, Frazier A, Carlin AF, Greenbaum JA, Peters B, Krammer F, Smith DM, Crotty S, Sette A. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181:1489–501.
Article
CAS
Google Scholar
Heymann DL. Polio eradication: finishing the job and protecting the investment. Bull World Health Organ. 2004;82:1.
Google Scholar
Jo WK, Drosten C, Drexler JF. The evolutionary dynamics of endemic human coronaviruses. Virus Evol. 2021;7:veab020.
Article
Google Scholar
Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296:356–9.
Article
CAS
Google Scholar
Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ. 2004;82:16–23.
Google Scholar
Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35:1547–9.
Article
CAS
Google Scholar
Lai MM. Coronavirus: organization, replication and expression of genome. Annu Rev Microbiol. 1990;44:303–33.
Article
CAS
Google Scholar
Lai MM, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res. 1997;48:1–100.
Article
CAS
Google Scholar
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New Engl J Med. 2020;382:1199–207.
Article
CAS
Google Scholar
Li Q, Wang J, Tang Y, Lu H. Next-generation COVID-19 vaccines: opportunities for vaccine development and challenges in tackling COVID-19. Drug Discov Ther. 2021;15:118–23.
Article
CAS
Google Scholar
Liu Y, Zhang X, Liu J, Xia H, Zou J, Muruato AE, Periasamy S, Plante JA, Bopp NE, Kurhade C, Bukreyev A, Ren P, Wang T, Vineet DM, Plante KS, Xie X, Weaver SC, Shi PY. A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. bioRxiv. (2022).
Lohrasbi-Nejad A. Detection of homologous recombination events in SARS-CoV-2. Biotechnol Lett. 2022;44:399–414.
Article
CAS
Google Scholar
Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73:152–60.
Article
CAS
Google Scholar
Maitra A, Sarkar MC, Raheja H, Biswas NK, Chakraborti S, Singh AK, Ghosh S, Sarkar S, Patra S, Mondal RK, Ghosh T, Chatterjee A, Banu H, Majumdar A, Chinnaswamy S, Srinivasan N, Dutta S, Das S. Mutations in SARS-CoV-2 viral RNA identified in Eastern India: possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility. J Biosci. 2020;45:1–18.
Article
Google Scholar
Martin DP, Williamson C, Posada D. RDP2: recombination detection and analysis from sequence alignments. Bioinformatics. 2005;21:260–2.
Article
CAS
Google Scholar
Motamedi H, Ari MM, Dashtbin S, Fathollahi M, Hossainpour H, Alvandi A, Moradi J, Abiri R. An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages. Int Immunopharmacol. 2021;96:107763.
Article
CAS
Google Scholar
Nikolaidis M, Papakyriakou A, Chlichlia K, Markoulatos P, Oliver SG, Amoutzias GD. Comparative analysis of SARS-CoV-2 variants of concern, including omicron, highlights their common and distinctive amino acid substitution patterns, especially at the spike ORF. Viruses. 2022;14:707.
Article
CAS
Google Scholar
Nugent MA. The future of the COVID-19 pandemic: How good (or bad) can the SARS-CoV2 spike protein get? Cells. 2022;11:855.
Article
CAS
Google Scholar
Seo SH, Jang Y. Cold-adapted live attenuated SARS-Cov-2 vaccine completely protects human ACE2 transgenic mice from SARS-Cov-2 infection. Vaccines (Basel). 2020;8:584.
Article
CAS
Google Scholar
Souza PFN, Mesquita FP, Amaral JL, Landim PGC, Lima KRP, Costa MB, Farias IR, Belem MO, Pinto YO, Moreira HHT, Magalhaes ICL, Castelo-Branco D, Montenegro RC, de Andrade CR. The spike glycoprotein of SARS-CoV-2: a review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape. Int J Biol Macromol. 2022;208:105–25.
Article
CAS
Google Scholar
Trimpert J, Dietert K, Firsching TC, Ebert N, Thao TN, Vladimirova T, Kaufer D, Labroussaa S, Abdelgawad F, Conradie A, Hofler A, Adler T, Bertzbach JM, Jores LD, Gruber J, Thiel AD, Osterrieder V, Kunec N. Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding. Cell Rep. 2021;36:109493.
Article
CAS
Google Scholar
Wang W, Li CP, He M, Li SW, Cao L, Ding NZ, He CQ. The dominant strain of SARS-CoV-2 is a mosaicism. Virus Res. 2021;305:198553.
Article
CAS
Google Scholar
Wang Y, Yang C, Song Y, Coleman JR, Stawowczyk M, Tafrova J, Tasker S, Boltz D, Baker R, Garcia L, Seale O, Kushnir A, Wimmer E, Mueller S. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy. Proc Natl Acad Sci U S A. 2021;118:e2102775118.
Article
CAS
Google Scholar
World-Health-Organization. Progress towards global eradication of poliomyelitis, 2002. Relev Epidemiol Hebd. 2003;78:138–44.
Google Scholar
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus, Research I, T. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020;382:727–733.